MLND - Millendo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Millendo Therapeutics's activity chart (see below) currently has 11 price targets and 10 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 271.25 days.

Most recent stock forecast was given by from LADENBURG on 06-Jan-2021. First documented stock forecast 16-Jul-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Apr-2020

Buy Since 11-Mar-2020

$25

Buy Since 07-Feb-2020

$20

$16.71 (507.90%)

$23

Buy Since 16-Jul-2019

$25

$21.71 (659.88%)

Show more analysts

What is MLND (Millendo Therapeutics) average time for price targets to be met?

On average it took 271.25 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on MLND (Millendo Therapeutics) with a proven track record?

JAY OLSON

Which analyst has the most public recommendations on MLND (Millendo Therapeutics)?

Jay Olson works at OPPENHEIMER and has 7 price targets and 9 ratings on MLND

Which analyst is the currently most bullish on MLND (Millendo Therapeutics)?

Jay Olson with highest potential upside - $21.71

Which analyst is the currently most reserved on MLND (Millendo Therapeutics)?

Laura Chico with lowest potential downside - -$0